TGF Beta 1 specific antibodies

Details for Australian Patent Application No. 2006240056 (hide)

Owner Eli Lilly and Company

Inventors Dickinson, Craig Duane; Watkins, Jeffry Dean; Vaillancourt, Peter Edward; Tang, Ying; Rowlinson, Scott William; Davies, Julian; Jones, Bryan Edward; Marquis, David Matthew; Huang, Lihua

Agent Spruson & Ferguson

Pub. Number AU-B-2006240056

PCT Pub. Number WO2006/116002

Priority 60/674,082 22.04.05 US

Filing date 20 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 16 February 2012

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/116002 Priority application(s): WO2006/116002

16 February 2012 Application Accepted

  Published as AU-B-2006240056

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006240057-Hybrid orthogonal frequency division multiple access system and method

2006240051-Kit for providing sweeteners having non-standard sweetness levels